Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest CAXTON CORP Stock Portfolio

$17.55Million– No. of Holdings #11

CAXTON CORP Performance:
2024 Q1: 8.37%YTD: 8.37%2023: 67.98%

Performance for 2024 Q1 is 8.37%, and YTD is 8.37%, and 2023 is 67.98%.

About CAXTON CORP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, CAXTON CORP reported an equity portfolio of $17.6 Millions as of 31 Mar, 2024.

The top stock holdings of CAXTON CORP are XERS, RZLT, SPY. The fund has invested 64.4% of it's portfolio in XERIS BIOPHARMA HOLDINGS INC and 19.2% of portfolio in REZOLUTE INC.

The fund managers got completely rid off SAVARA INC (SVRA), APOGEE THERAPEUTICS INC and HARPOON THERAPEUTICS INC (HARP) stocks. They significantly reduced their stock positions in XERIS BIOPHARMA HOLDINGS INC (XERS) and ABIVAX SA. CAXTON CORP opened new stock positions in KYVERNA THERAPEUTICS INC, MIND MEDICINE MINDMED INC (MNMD) and ADICET BIO INC (ACET). The fund showed a lot of confidence in some stocks as they added substantially to SPDR S&P 500 ETF TR (SPY).
CAXTON CORP Equity Portfolio Value
Last Reported on: 15 May, 2024

CAXTON CORP Annual Return Estimates Vs S&P 500

Our best estimate is that CAXTON CORP made a return of 8.37% in the last quarter. In trailing 12 months, it's portfolio return was 62.43%.

New Buys

Ticker$ Bought
kyverna therapeutics inc393,614
mind medicine mindmed inc273,207
adicet bio inc41,096

New stocks bought by CAXTON CORP

Additions

Ticker% Inc.
spdr s&p 500 etf tr40.39

Additions to existing portfolio by CAXTON CORP

Reductions

Ticker% Reduced
xeris biopharma holdings inc-9.37
abivax sa-5.58
berkshire hathaway inc del-1.55

CAXTON CORP reduced stake in above stock

Sold off

Ticker$ Sold
savara inc-1,661,170
allakos inc-67,457
harpoon therapeutics inc-129,291
apogee therapeutics inc-205,436

CAXTON CORP got rid off the above stocks

Sector Distribution

CAXTON CORP has about 87.6% of it's holdings in Healthcare sector.

Sector%
Healthcare87.6
Others12.4

Market Cap. Distribution

CAXTON CORP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP65.9
MICRO-CAP19.9
UNALLOCATED12.4
NANO-CAP1.7

Stocks belong to which Index?

About 65.1% of the stocks held by CAXTON CORP either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200065.1
Others34.9
Top 5 Winners (%)%
RZLT
rezolute inc
156.9 %
MNMD
mind medicine mindmed inc
91.5 %
CMPX
compass therapeutics inc
26.9 %
SPY
spdr s&p 500 etf tr
8.4 %
Top 5 Winners ($)$
RZLT
rezolute inc
2.1 M
MNMD
mind medicine mindmed inc
0.1 M
SPY
spdr s&p 500 etf tr
0.1 M
CMPX
compass therapeutics inc
0.0 M
Top 5 Losers (%)%
MTEM
molecular templates inc
-40.0 %
XERS
xeris biopharma holdings inc
-5.0 %
ACET
adicet bio inc
-3.7 %
Top 5 Losers ($)$
XERS
xeris biopharma holdings inc
-0.7 M
MTEM
molecular templates inc
-0.2 M
ACET
adicet bio inc
0.0 M

CAXTON CORP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of CAXTON CORP

CAXTON CORP has 11 stocks in it's portfolio. XERS proved to be the most loss making stock for the portfolio. RZLT was the most profitable stock for CAXTON CORP last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions